Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on: February 18,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on:February 18,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on: December 25,2023

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on:December 25,2023

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe

Updated on: July 09,2024

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe

Updated on:July 09,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on: June 17,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on:June 17,2024

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on: June 11,2024

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on:June 11,2024

Preclinical study finds novel bone cancer therapy has 99% success rate

byAston UniversityProfessor Richard Martin. Credit: Aston UniversityBioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined

Updated on: September 27,2024

Preclinical study finds novel bone cancer therapy has 99% success rate

byAston UniversityProfessor Richard Martin. Credit: Aston UniversityBioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined

Updated on:September 27,2024

Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Updated on: March 30,2024

Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Updated on:March 30,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on: January 22,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on:January 22,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1

Updated on: December 30,2023

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1

Updated on:December 30,2023

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024